Skip to main content

Day: December 22, 2025

Umicore – Transparency notification by JP Morgan Asset Management Holdings Inc.

Transparency notification by JP Morgan Asset Management Holdings Inc. In accordance with article 14, § 1 of the law of 2 May 2007 on the disclosure of major holdings, Umicore was recently notified by JP Morgan Asset Management Holdings Inc. that its subsidiary JP Morgan Asset Management (UK) Limited has crossed the legal threshold of 3% for the direct voting rights and equivalent financial instruments upwards on 15 December 2025. The total holding of direct voting rights and equivalent financial instruments of JP Morgan Asset Management Holdings Inc. stands at 3.41% on 15 December 2025. Summary of the move by JP Morgan Asset Management (UK) Limited, a subsidiary of JP Morgan Asset Management Holdings Inc:Date on which the threshold was crossed Date of notification Direct voting rights after the transaction Equivalent financial instruments...

Continue reading

Tevogen CEO Donates Shares to Support Education for Underprivileged Children

WARREN, N.J., Dec. 22, 2025 (GLOBE NEWSWIRE) — Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today announced that its Founder and CEO, Dr. Ryan Saadi has made a charitable contribution of 230,000 shares of Tevogen common stock to SRLC USA, a United Nations-recognized 501(c)(3) nonprofit organization dedicated to serving underserved communities. “Education is one of the most powerful long-term investments we can make in building healthier, more equitable societies,” said Dr. Saadi. “I’m pleased to support an organization that is deeply committed to uplifting underserved communities through meaningful, measurable action.” The donation was conducted in accordance with SEC Rule 144 and Dr. Saadi will not receive any proceeds from the disposal of the securities. About Tevogen Tevogen is a next-generation, socially...

Continue reading

Bimergen Energy Uplist to the NYSE American Stock Exchange with Concurrent Offering to Occur upon SEC Effectiveness

Newport Beach, CA, Dec. 22, 2025 (GLOBE NEWSWIRE) — Bimergen Energy Corporation (OTCQB: BESS) (“Bimergen”), a utility-scale battery energy storage systems (BESS) asset owner, project developer, and independent power provider, today announced that its shares of common stock have been approved for listing on the NYSE American LLC (“NYSE American”) stock exchange. Bimergen expects that its common stock will begin trading on the NYSE American under the symbol “BESS” upon effectiveness of its registration statement and authorization of the application and continued satisfaction of NYSE American rules. In connection with the anticipated uplisting, Bimergen is also conducting a concurrent offering of its securities, subject to market conditions. Additional details regarding the offering will be provided through the Company’s...

Continue reading

Sanofi: Information concerning the total number of voting rights and shares – November 2025

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority) Sanofia French société anonyme with a registered share capital of €2,438,854,192Registered office : 46, avenue de la Grande Armée – 75017 Paris – FranceRegistered at the Paris Commercial and Companies Registry under number 395 030 844Date   Total number of issued shares   Number of real voting rights(excluding treasury shares) Theoretical number of voting rights (including treasury shares)*30 November 2025   1,227,469,992   1,345,585,094   1,361,665,420* Pursuant to Article 223-11 of the Règlement général de l’Autorité des Marchés...

Continue reading

Orrön Energy sells a portfolio of three solar energy projects in Germany for a total consideration of up to MEUR 14

Orrön Energy AB (“Orrön Energy” or “the Company”) is pleased to announce that it has entered into an agreement with Gülermak Renewables Deutschland Holding GmbH (“Gülermak”), 100% subsidiary of Gülermak Renewables Ltd to sell three solar energy development projects in Germany, with a combined estimated installed capacity of 234 MW, for a total consideration of up to MEUR 14. The consideration paid at closing for the first project is expected to be MEUR 0.7, with the remaining consideration contingent on development milestones being met up to the ready-to-build stage.  The projects are located in eastern Germany and are being developed as Agri-PV projects with co-located battery options, enabling agricultural activities to take place alongside solar power generation. The projects are in a pre-ready-to-permit stage and are being developed...

Continue reading

Beamr’s Benchmark Testing Validates ML-Safe Video Data Workflows for Autonomous Vehicles

Testing demonstrates 48% file size reduction with robust ML model accuracy across multiple industry-standard metrics. AV teams are invited to meet Beamr at CES 2026, January 6-9 in Las Vegas Herzliya, Israel, Dec. 22, 2025 (GLOBE NEWSWIRE) — Beamr Imaging Ltd. (NASDAQ: BMR), a leader in video optimization technology and solutions, published benchmark testing results validating that its patented Content-Adaptive Bitrate (CABR) technology delivers up to 50% storage reduction for autonomous vehicle (AV) video data with comprehensive technical demonstration of machine learning (ML) model accuracy. AV teams and developers attending CES 2026 in Las Vegas, from January 6-9, 2026, are invited to schedule a meeting with Beamr’s video data experts to review the results and discuss ML-safe AV pipelines. To schedule a meeting at CES 2026,...

Continue reading

AB Science patent for masitinib in the treatment of sickle cell disease formally granted in the US with a protection until 2040

PRESS RELEASE AB SCIENCE PATENT FOR MASITINIB IN THE TREATMENT OF SICKLE CELL DISEASE FORMALLY GRANTED IN THE UNITED STATES WITH A PROTECTION UNTIL 2040 THIS DECISION STRENGTHENS MASITINIB’S INTELLECTUAL PROPERTY PORTFOLIO WITH LONG-TERM PROTECTION FOR AN ADDITIONAL INDICATION WITH A HIGH UNMET MEDICAL NEED THE BIOMARKER PHASE 2 IN COOPERATION WITH AP-HP IS FULLY FUNDED Paris, December 22, 2025, 6pm CET AB Science SA (Euronext – FR0010557264 – AB) today announced that the United States Patent Office has formally granted a patent for methods of treating sickle cell disease (i.e., a medical use patent) using its lead compound masitinib, based on preclinical data. This new US patent (US12,472,164) ensures intellectual property protection for masitinib until November 2040.Masitinib : An innovation in sickle cell diseaseSickle...

Continue reading

Aramis Group – Declaration of transactions on own shares conducted from Dec 15 to Dec 19, 2025

PRESS RELEASE Arcueil, December 22, 2025 Declaration of transactions on own shares conducted from December 15 to December 19, 2025 Within the framework of the authorizations granted by the General Assembly on February 4, 2025, to operate on its shares and in accordance with the regulations related to share buybacks, Aramis Group hereby declares the following purchases of own shares (FR0014003U94) made from December 15 to December 19, 2025 (excluding the liquidity contract):Name of the issuer Issuer identifier code Transaction date Financial instrument identifier code Total daily volume (in number of shares) Daily weighted average purchase price of shares MarketAramis Group 9695002Q984W0T41WB42 2025-12-15 FR0014003U94 4,577 4.3694 XPARAramis Group 9695002Q984W0T41WB42 2025-12-16 FR0014003U94 4,620 4.3287 XPARAramis Group 9695002Q984W0T41WB42 2025-12-17 FR0014003U94 4,687 4.2671 XPARAramis...

Continue reading

Solo Brands, Inc. Announces Corporate Simplification to Establish a Single Class of Common Stock and Limit Its Tax Receivable Agreement

Strategic Actions to Align with Shareholders’ Interests and Significant Cash Savings Expected GRAPEVINE, Texas, Dec. 22, 2025 (GLOBE NEWSWIRE) — Solo Brands, Inc. (NYSE: SBDS) (“Solo Brands” or “the Company”) a leading portfolio of lifestyle brands (Solo Stove, Chubbies, Isle and Oru) that are redefining the outdoor and apparel industries, announced that it is conducting a series of transactions that will simplify its organizational structure, including the elimination of its umbrella partnership C corporation (Up-C) structure, which has the effect of limiting material liability for potential cash payments under its Tax Receivable Agreement (the “TRA”). “We are simplifying our corporate structure to strengthen governance and align with shareholder interests. Capping the tax receivable agreement lowers future obligations,...

Continue reading

MicroCloud Hologram Inc. Develops Serial-Parallel Architecture-Based FPGA Quantum Computing Simulation Framework

SHENZHEN, China, Dec. 22, 2025 (GLOBE NEWSWIRE) — MicroCloud Hologram Inc. (NASDAQ: HOLO), (“HOLO” or the “Company”), a technology service provider, launched a brand-new FPGA-based quantum computing simulation framework founded on a serial-parallel architecture. This framework adopts an innovative hardware-level data path design and, by redefining the execution mode of quantum gate operations, achieves a linear reduction in resource utilization. This framework not only demonstrates the inherent advantages of hardware-simulated quantum systems in terms of speed and parallelism but also marks a key step taken by HOLO in the direction of quantum computing hardware acceleration. This technology has been validated on core quantum algorithms such as Quantum Fourier Transform (QFT) and Grover Search, providing a scalable path...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.